Literature DB >> 8956022

Eye disease in sickling disorders.

S Charache1.   

Abstract

When treating patients with sickling disorders, hematologists and oncologists should know those eye lesions that require referral to an ophthalmologist, those that should lead to referral, and those that rarely are associated with decreased vision. Hyphema in any patient whose red cells contain hemoglobin S falls into the first category. Retinal neovascularization (proliferative retinopathy) and its consequence vitreous hemorrhage fall into the second. The comma sign, angioid streaks, and abnormal color vision fall into the third category. The roles of preoperative transfusion and experimental antisickling therapy in treatment and prevention of eye lesions are incompletely defined at present.

Entities:  

Mesh:

Year:  1996        PMID: 8956022     DOI: 10.1016/s0889-8588(05)70406-8

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  4 in total

Review 1.  Ocular and systemic causes of retinopathy in patients without diabetes mellitus.

Authors:  Jayant Venkatramani; Paul Mitchell
Journal:  BMJ       Date:  2004-03-13

2.  Sickle cell disease: an opportunity for palliative care across the life span.

Authors:  Diana J Wilkie; Bonnye Johnson; A Kyle Mack; Richard Labotka; Robert E Molokie
Journal:  Nurs Clin North Am       Date:  2010-09       Impact factor: 1.208

Review 3.  Sickle cell retinopathy: improving care with a multidisciplinary approach.

Authors:  Farid Menaa; Barkat Ali Khan; Bushra Uzair; Abder Menaa
Journal:  J Multidiscip Healthc       Date:  2017-08-30

4.  Transfusion practices in the management of sickle cell disease: a survey of Florida hematologists/oncologists.

Authors:  Levette N Dunbar; Larae Coleman Brown; Donna R Rivera; Abraham G Hartzema; Richard Lottenberg
Journal:  ISRN Hematol       Date:  2012-12-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.